Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.422EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.125.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.78 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XATEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used